NeuroFrontiers

Gulf War Illness is a chronic condition characterized by physiological and psychological symptoms, including cognitive dysfunction, memory problems, and depression. But what’s currently known about this debilitating condition that affects nearly 30 percent of Gulf War veterans? And how can we treat them? Find out with Dr. Jerome Lisk as he speaks with Dr. Ashok Shetty from Texas A&M University College of Medicine.

When it comes to managing multiple sclerosis (MS), it’s important to keep the patient at the center of care by learning about their unique goals as well as the sociodemographic and socioeconomic factors affecting them. So how can we learn more about our patients, and once we do, what evidence-based management strategies are available to us? Joining Dr. Charles Turck to share how we can tailor treatment plans for our patients with MS are Dr. Vikram Bhise and certified assistive technology practitioner Ms. Patty Bobryk.

Shared decision-making is essential when it comes to caring for patients with multiple sclerosis. But what does its utilization actually look like in practice? To find out, Dr. Paul Doghramji speaks with Dr. Vikram Bhise, who shares a patient case in multiple sclerosis care that demonstrates how we can incorporate shared decision-making in practice.

Although research suggests that women have a similar stroke risk as men, a new analysis has found that a very small percentage of participants in clinical trials investigating stroke treatments are female. So why are women underrepresented in these clinical trials, and what can be done to reverse this troubling trend? Joining Dr. Andrew Wilner to discuss strategies to improve the representation of women in stroke trials is Dr. Cheryl Carcel, neurologist and senior research fellow at the George Institute of Global Health.

The Diagnostic and Statistical Manual of Mental Disorders (DSM) is the handbook traditionally used by healthcare professionals to guide the diagnosis of psychiatric conditions, but a number of psychiatrists advocate for the perspectives approach, which extends beyond the DSM model. So how exactly do these two models differ? And how might this newer approach impact our patients? Joining Dr. Charles Turck to answer those and other key questions on the perspectives approach to diagnosing and treating patients with mental illness is Dr. Margaret Chisolm, author of From Survive to Thrive: Living Your Best Life with Mental Illness.

Schizophrenia is rarely a single-episode illness. In fact, 8 out of 10 patients will experience a relapse of symptoms after initial treatment. So how can we help reduce the frequency of relapse—and even non-adherence—among our patients with schizophrenia? To find out, Dr. Andrew Wilner is joined by Dr. Jose Rubio, psychiatrist at Long Island Jewish Medical Center and Assistant Professor at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, to talk about the use of long-acting injectable (LAI) antipsychotics for schizophrenia treatment.

Pediatric multiple sclerosis (MS) occurs in more than 8,000 children in the United States alone, but there’s little data regarding these patients’ quality of life. That’s why Dr. Vikram Bhise recently conducted research to gain a better understanding of pediatric MS patients’ quality of life as they transition into adulthood. And now, Dr. Bhise joins Dr. Jennifer Caudle to share the results that were presented at the 2021 Consortium of Multiple Sclerosis Centers (CMSC) Annual Meeting.

The rehabilitation track at the 2021 Consortium of Multiple Sclerosis Centers (CMSC) was filled with key updates regarding collaboration, nonpharmaceutical symptom management strategies, and more. And Ms. Patty Bobryk, a physical therapist at Yampa Valley Medical Center, is here to review those updates with us.

A multidisciplinary approach to multiple sclerosis (MS) is becoming more and more integral in practice as research continues to emerge on its significance. That’s why physical therapist Ms. Patty Bobryk is here to debrief us on some highlights from the rehabilitation track at the 2021 Consortium of Multiple Sclerosis Centers (CMSC) that focused on collaborative care.

Since the onset of the COVID-19 pandemic, researchers and clinicians alike have strived to address the mysteries surrounding the virus, including its long-term side effects on patients. So what we do need to know about the emerging syndrome pointing to COVID-19’s neurological and cognitive impacts? To find out, Dr. Jerome Lisk is joined by Dr. Tissa Wijeratne, the Director of the Department of Neurology and Stroke Services at the University of Melbourne, to talk about post-COVID-19 neurological syndrome.